GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Biofrontera Inc.
Biofrontera is a pharmaceutical company specializing in the treatment of skin cancer. Its stock price depends on sales of its photodynamic therapy system and success in expanding its use to new indications.
Share prices of companies in the market segment - Pharma skin
Biofrontera Inc. specializes in the commercialization of dermatological drugs, particularly for the treatment of actinic keratosis (a precancerous skin condition). We have classified it in the Pharma: Skin category. The chart below shows how investors value companies in the stable dermatology sector.
Broad Market Index - GURU.Markets
Biofrontera is a pharmaceutical company specializing in the development and marketing of photodynamic therapy for skin cancer. Its focus on dermatology makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Biofrontera compares to it.
Change in the price of a company, segment, and market as a whole per day
BFRI - Daily change in the company's share price Biofrontera Inc.
For Biofrontera Inc., a company focused on photodynamic therapy for skin cancer, daily volatility reflects the sensitivity of its drug sales. This metric is an indicator of demand for its products from dermatologists.
Daily change in the price of a set of shares in a market segment - Pharma skin
Biofrontera specializes in dermatology drugs, particularly for the treatment of skin cancer. The pharmaceutical sector is sensitive to clinical trial results and regulatory decisions. The chart below shows the average volatility of the segment, which can help you understand whether BFRI price fluctuations are unique or typical for the industry.
Daily change in the price of a broad market stock, index - GURU.Markets
Biofrontera is a pharmaceutical company focused on dermatology. Its shares are driven by successful drug commercialization and clinical trial results. The dynamics of this niche healthcare segment are part of a larger and more diverse picture of the overall stock market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Biofrontera Inc.
Biofrontera Inc.'s year-over-year performance tells the story of its drug development for the treatment of actinic keratosis (a precancerous skin condition). Its 12-month market capitalization growth reflects the sales volume of its photodynamic therapy, as well as its ability to compete with other treatments in the U.S. dermatology market.
Annual dynamics of market capitalization of the market segment - Pharma skin
Biofrontera Inc. is a commercial pharmaceutical company specializing in dermatology. This chart shows how its sales performance, competition, and portfolio expansion efforts impact its performance in the pharmaceutical sector, where it is a niche player.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Biofrontera, a company specializing in dermatological photodynamic therapy, demonstrates growth driven by the commercial success of its products. Comparing its annual market capitalization to the market allows us to assess how sales growth and geographic expansion impact its valuation and whether its business model is resilient to general economic fluctuations.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Biofrontera Inc.
Biofrontera is a commercial-to-market dermatology company. Its monthly performance reflects sales of its photodynamic therapy products. Quarterly revenue and profitability reports, as well as market competition, are key factors influencing its valuation.
Monthly dynamics of market capitalization of the market segment - Pharma skin
Biofrontera Inc. is a biopharmaceutical company specializing in the commercialization of dermatological products, specifically photodynamic therapy for the treatment of actinic keratosis. The dynamics of its sector, shown in the graph, serve as background. It will be interesting to assess how its niche therapy competes in the market for sun-induced skin conditions.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Biofrontera commercializes drugs for the treatment of skin diseases. Its stock price is driven by sales volume and marketing efforts. The chart shows how the stock reacts to quarterly revenue reports, making it more predictable than research-stage biotechs, but still niche.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Biofrontera Inc.
Biofrontera is a pharmaceutical company specializing in dermatology. Its weekly stock price performance is driven by sales of its photodynamic therapy products and competition in the skin treatment market.
Weekly dynamics of market capitalization of the market segment - Pharma skin
Biofrontera Inc. specializes in dermatological drugs. The chart compares the weekly stock performance of this niche company with the broader pharmaceutical sector. Does its niche allow it to chart a trajectory independent of global industry trends?
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Biofrontera Inc. is a pharmaceutical company whose stock moves to the rhythm of news about clinical trials and partnerships. The chart clearly shows how its weekly performance is detached from the broader market, moving along its own unique trajectory.
Market capitalization of the company, segment and market as a whole
BFRI - Market capitalization of the company Biofrontera Inc.
Biofrontera's market capitalization is a story about the commercialization of photodynamic therapy. This company's chart, which sells a drug for the treatment of actinic keratosis (a precancerous skin condition), shows how investors view its ability to grow sales in the dermatology market.
BFRI - Share of the company's market capitalization Biofrontera Inc. within the market segment - Pharma skin
Biofrontera specializes in the commercialization of dermatological products, particularly photodynamic therapy for actinic keratosis (a precancerous skin condition). Within the skin pharmaceutical segment, its market capitalization reflects its niche position. The company's market share is an indicator of the commercial success of its products in the US market.
Market capitalization of the market segment - Pharma skin
Biofrontera is a dermatology pharmaceutical company. How big is the skincare industry? The chart below shows the overall market capitalization of this sector. Its growth reflects both the medical need to treat skin cancer and the aesthetic desire to maintain healthy, youthful skin.
Market capitalization of all companies included in a broad market index - GURU.Markets
The Biofrontera chart shows how the market values a company specializing in dermatology. Its market capitalization is based on the commercialization of its photodynamic therapy for skin cancer. This diagram illustrates how a highly specialized product is struggling to maintain its market share.
Book value capitalization of the company, segment and market as a whole
BFRI - Book value capitalization of the company Biofrontera Inc.
Biofrontera's book value is derived from its tangible assets, primarily its commercial infrastructure in the US for selling photodynamic therapy products for skin diseases. The chart below shows how the value of this sales-oriented tangible foundation has changed.
BFRI - Share of the company's book capitalization Biofrontera Inc. within the market segment - Pharma skin
Biofrontera Inc. is a dermatology pharmaceutical company. Its assets are not manufacturing plants, but commercial infrastructure: distribution centers and offices that support the sales of its photodynamic therapy products. The chart shows how its sales-oriented tangible assets compare to the sector.
Market segment balance sheet capitalization - Pharma skin
Biofrontera is a biopharmaceutical company. Pharmaceuticals, as the graph shows, are both knowledge- and capital-intensive. As a commercial company, Biofrontera invests not only in R&D but also in the infrastructure to market its dermatological products.
Book value of all companies included in the broad market index - GURU.Markets
Biofrontera's assets are not its manufacturing plants, but rather its commercial infrastructure in the US for selling photodynamic therapy for actinic keratosis, a precancerous skin condition. Its book value reflects its operational capabilities and distribution rights.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Biofrontera Inc.
Biofrontera is a pharmaceutical company specializing in photodynamic therapy for the treatment of skin cancer. Its value lies in its product and system. The chart shows how the market views its commercial efforts in the dermatology market.
Market to book capitalization ratio in a market segment - Pharma skin
Biofrontera is a pharmaceutical company specializing in dermatology. Its valuation is based on sales of its skin treatment products. The chart shows how the market views its commercial strategy and market share.
Market to book capitalization ratio for the market as a whole
Biofrontera is a pharmaceutical company specializing in dermatology. Sales of its core product and brand are important components of its valuation. This chart helps understand how the market values niche pharmaceutical companies with established cash flow compared to purely research-based biotechs.
Debts of the company, segment and market as a whole
BFRI - Company debts Biofrontera Inc.
Biofrontera specializes in photodynamic therapy for dermatology. Commercializing its medical products requires capital for marketing to dermatologists and supply chain management. This chart illustrates how the company uses debt to finance its sales and market expansion efforts.
Market segment debts - Pharma skin
Biofrontera is a pharmaceutical company specializing in photodynamic therapy in dermatology. The company has commercial products but is also investing in expanding their applications. This chart shows how it balances marketing and R&D.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Biofrontera Inc.
Biofrontera is a pharmaceutical company specializing in dermatology. This chart shows its financial structure. For a company with marketable products, moderate debt may be normal. However, investors should be careful not to let it become excessive, limiting investments in marketing and R&D.
Market segment debt to market segment book capitalization - Pharma skin
Biofrontera specializes in photodynamic therapy for the treatment of actinic keratosis and other skin conditions. This chart shows the overall debt burden in the pharmaceutical industry, which helps assess how the company finances the commercialization of its products and competition in the dermatology market.
Debt to book value of all companies in the market
Biofrontera Inc. is a pharmaceutical company specializing in dermatology. With a commercial product, it can use debt to fund marketing and sales expansion. This chart provides context for assessing how aggressively the company is using leverage to grow in the photodynamic therapy and other dermatology treatments market.
P/E of the company, segment and market as a whole
P/E - Biofrontera Inc.
This metric for Biofrontera, a pharmaceutical company specializing in dermatology, measures the valuation of its commercial products. The P/E reflects the sales of its skin treatments and its ability to compete in this market. It's a valuation of a niche pharmaceutical business.
P/E of the market segment - Pharma skin
Biofrontera is a specialty biopharmaceutical company focused on commercializing dermatological products, specifically for the treatment of actinic keratosis. This chart shows the average valuation for the sector, helping to understand how the market views this niche player.
P/E of the market as a whole
Biofrontera is a pharmaceutical company specializing in dermatology. Its valuation depends on the commercial success of its skin treatment products. General market sentiment, reflected in this chart, has little impact on its business, which is determined by the specifics of its niche market and competition.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Biofrontera Inc.
Biofrontera is a biopharmaceutical company specializing in dermatology products, specifically photodynamic therapy for the treatment of actinic keratosis. This chart reflects sales expectations for its key product. Future profitability depends on demand for its therapy and competition in the dermatology market.
%20P%2FE%20Biofrontera%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Biofrontera-Inc.&v=1772553599631 "Chart of the company's future (projected) P/E Biofrontera Inc.")
Future (projected) P/E of the market segment - Pharma skin
Biofrontera specializes in the commercialization of dermatological products, specifically photodynamic therapy for the treatment of actinic keratosis. Its valuation relative to other pharmaceutical companies reflects investor sentiment about its niche products, demonstrating how the market views its sales strategy and growth potential.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-skin&v=1772553599706 "Future (projected) P/E graph of the market segment - Pharma skin")
Future (projected) P/E of the market as a whole
Biofrontera is a pharmaceutical company specializing in dermatology. It sells drugs for the treatment of actinic keratosis (a precancerous skin condition). Its success depends on growing sales of its existing products. This chart shows the overall sentiment in the healthcare sector, which influences the valuation of small commercial pharmaceutical companies.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772553599756 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Biofrontera Inc.
Biofrontera specializes in dermatology and commercializes photodynamic therapy products and devices used to treat actinic keratosis (a precancerous skin condition). Financial results presented here are contingent on successful sales of its system in the United States.
Profit of companies in the market segment - Pharma skin
Biofrontera specializes in dermatological drugs, specifically photodynamic therapy for actinic keratosis (a precancerous skin condition). This chart shows the overall profitability of the dermatological pharmaceutical sector. It helps understand the profitability of the market for sun-related treatments.
Overall market profit
Biofrontera specializes in the commercialization of dermatological drugs. Its success depends on the effectiveness of sales, marketing, and insurance coverage for its products. This business is less dependent on general economic cycles and more dependent on the specifics of the healthcare market.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Biofrontera Inc.
Biofrontera specializes in dermatology drugs, specifically photodynamic therapy for skin cancer. The company's future profitability depends on sales of its products. This chart reflects analyst expectations for demand for its therapies and its competitive position in the market.
%20profit%20of%20the%20company%20Biofrontera%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Biofrontera-Inc.&v=1772553599979 "Graph of future (projected) profit of the company Biofrontera Inc.")
Future (predicted) profit of companies in the market segment - Pharma skin
Biofrontera is a pharmaceutical company specializing in dermatology. It sells photodynamic therapy products and devices used to treat actinic keratosis and other skin conditions. This chart shows the outlook for the skin pharmaceutical industry. It helps assess how the company, focused on a narrow niche, competes in the dermatology market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-skin&v=1772553600019 "Graph of future (predicted) profits of companies in a market segment - Pharma skin")
Future (predicted) profit of the market as a whole
This graph shows the dynamics of consumer spending on healthcare and cosmetology. Biofrontera, which specializes in dermatological drugs, relies on consumer demand. Rising incomes support demand for both medical and aesthetic procedures.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772553600092 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Biofrontera Inc.
Biofrontera is a pharmaceutical company specializing in dermatological photodynamic therapy. This chart shows how the market values its current sales revenue and its ability to expand the application of its technology.
P/S market segment - Pharma skin
Biofrontera is a biopharmaceutical company specializing in dermatology and commercializing drugs for the treatment of sun-induced skin diseases. This chart shows the average valuation in the skin pharmaceuticals sector. It helps understand how investors view Biofrontera's products and its position in the photodynamic therapy market.
P/S of the market as a whole
Biofrontera Inc. is a pharmaceutical company specializing in dermatology. The company commercializes drugs and devices for photodynamic therapy of actinic keratosis (a precancerous skin condition). Revenue is driven by sales of this therapy. This chart helps assess the market value of a company with a niche product in dermatology.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Biofrontera Inc.
Biofrontera specializes in the commercialization of dermatological products, specifically photodynamic therapy for actinic keratosis. Future revenue depends on the successful sales of its products. The chart reflects the market's assessment of its commercial strategy and potential in the dermatological market.
%20P%2FS%20Biofrontera%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Biofrontera-Inc.&v=1772553600380 "The graph of the company's future (projected) P/S Biofrontera Inc.")
Future (projected) P/S of the market segment - Pharma skin
Biofrontera is a dermatology company that sells photodynamic therapy products and devices used to treat precancerous skin lesions. This chart shows how the market estimates its future sales in the dermatology market compared to other specialty pharmaceutical companies.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20skin&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-skin&v=1772553600385 "Future (projected) P/S market segment graph - Pharma skin")
Future (projected) P/S of the market as a whole
This indicator summarizes expectations for the dermatology market. For Biofrontera, a company developing photodynamic therapy for skin cancer, it reflects demand for non-invasive treatments. Market optimism supports the willingness of patients and physicians to choose modern and effective methods for combating common skin cancers.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772553600526 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Biofrontera Inc.
Biofrontera is a pharmaceutical company specializing in dermatology. It markets a drug for photodynamic therapy of actinic keratosis (a precancerous skin condition). This chart shows revenue from sales of this drug and related devices in the US. Sales growth reflects demand for non-invasive treatments for skin conditions.
Sales of companies in the market segment - Pharma skin
Biofrontera Inc. is a biopharmaceutical company specializing in dermatology. This chart shows the dynamics of the skin pharmaceutical sector. The company's main product is designed for photodynamic therapy of actinic keratosis, a precancerous skin condition, which is an important part of skin cancer prevention.
Overall market sales
Biofrontera Inc. is a pharmaceutical company specializing in dermatological products, particularly for the treatment of actinic keratosis. Its sales are driven by demand in the healthcare system. The overall economic situation, shown in this chart, influences patient and insurer spending on specialized skin treatments.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Biofrontera Inc.
Biofrontera specializes in the commercialization of dermatological drugs, specifically for photodynamic therapy of actinic keratosis (a precancerous skin condition). This chart shows analysts' forecasts for the growth of the dermatological treatment market and demand for the company's products.
%20sales%20of%20the%20company%20Biofrontera%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Biofrontera-Inc.&v=1772553600837 "Schedule of future (projected) sales of the company Biofrontera Inc.")
Future (projected) sales of companies in the market segment - Pharma skin
Biofrontera specializes in dermatological products, specifically photodynamic therapy for actinic keratosis. This chart shows expectations for the pharmaceutical skincare segment. It reflects the demand for effective treatments for precancerous skin conditions.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-skin&v=1772553600961 "Schedule of future (projected) sales of companies in the market segment - Pharma skin")
Future (projected) sales of the market as a whole
Biofrontera Inc. is a biopharmaceutical company specializing in dermatology and commercializing drugs for the treatment of skin diseases, particularly actinic keratosis. Its success depends on sales performance. This graph, reflecting overall consumer spending on healthcare, influences demand for the dermatological procedures and drugs the company offers.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772553601014 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Biofrontera Inc.
Biofrontera is a pharmaceutical company specializing in dermatology, specifically photodynamic therapy for skin cancer. This chart shows the company's profitability. Profit depends on sales of its drug and lamp, as well as insurance reimbursements and the effectiveness of its sales team.
Market segment marginality - Pharma skin
Biofrontera Inc. is a pharmaceutical company specializing in dermatological drugs, specifically photodynamic therapy for actinic keratosis. Profitability depends on the effectiveness of treatment and marketing. This chart shows the average profitability in the sector, allowing one to assess how well Biofrontera is performing in its niche.
Market marginality as a whole
Biofrontera is a pharmaceutical company specializing in dermatological drugs, specifically photodynamic therapy for actinic keratosis. This overall market profitability graph does not directly impact its performance. Demand for its products is determined by the prevalence of the disease and the preferences of physicians and patients.
Employees in the company, segment and market as a whole
Number of employees in the company Biofrontera Inc.
Biofrontera is a pharmaceutical company commercializing dermatology drugs in the US. This chart shows its commercial team, comprised primarily of sales and marketing specialists. Their size is a key factor in success in the competitive pharmaceutical market.
Share of the company's employees Biofrontera Inc. within the market segment - Pharma skin
Biofrontera Inc. specializes in dermatological products, specifically photodynamic therapy for actinic keratosis. This chart shows the percentage of dermatologists, biologists, and sales professionals the company attracts in its niche. It reflects the company's concentration of expertise and commercial efforts in the specific photodynamic therapy market.
Number of employees in the market segment - Pharma skin
Biofrontera is a pharmaceutical company specializing in dermatology, specifically photodynamic therapy for actinic keratosis (a precancerous skin condition). This graph shows that even in fields like dermatology, high-tech treatments are emerging that require specialized equipment and trained medical personnel.
Number of employees in the market as a whole
Biofrontera Inc. specializes in dermatological pharmaceuticals. The market for skin treatments is vast and constantly growing. This overall employment chart includes this dynamic segment, where innovations in acne and skin cancer treatments create demand for both scientific research and marketing and sales.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Biofrontera Inc. (BFRI)
Biofrontera specializes in the commercialization of dermatological drugs, particularly photodynamic therapy. This chart reflects the value of its "intellectual capital." The company's assets are not its manufacturing plants, but rather its licenses and rights to market its drugs and devices. The chart shows the market value of this portfolio of commercial rights per employee.
%20of%20the%20company%20Biofrontera%20Inc.%20(BFRI)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Biofrontera-Inc.-BFRI&v=1772553601956 "Chart of market capitalization per employee (in thousands of dollars) of the company Biofrontera Inc. (BFRI)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma skin
Biofrontera specializes in dermatology drugs, particularly photodynamic therapy. The chart shows how the market values their product portfolio and commercial team. Comparison with the sector helps understand how effectively they are monetizing their expertise in dermatology.
%20by%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-skin&v=1772553602043 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma skin")
Market capitalization per employee (in thousands of dollars) for the overall market
Biofrontera Inc. is a pharmaceutical company specializing in dermatological products. This chart shows the market-wide per-employee performance metric, which helps evaluate a company with commercialized products.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772553602382 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Biofrontera Inc. (BFRI)
Biofrontera is a pharmaceutical company specializing in dermatology. They have commercial products. This chart shows how effectively their sales team generates revenue. It reflects the profit margins of their drugs and photodynamic therapy per employee.
%20Chart%20Biofrontera%20Inc.%20(BFRI)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Biofrontera-Inc.-BFRI&v=1772553602432 "Company Profit Per Employee (in thousands of dollars) Chart Biofrontera Inc. (BFRI)")
Profit per employee (in thousands of dollars) in the market segment - Pharma skin
Biofrontera Inc. is a pharmaceutical company specializing in dermatology and commercializing photodynamic therapy for actinic keratosis. Its business is focused on sales and marketing. This chart shows how effectively the sales team promotes the product, a key indicator of success for specialty pharmaceutical companies.
%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-skin&v=1772553602481 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma skin")
Profit per employee (in thousands of dollars) for the market as a whole
Biofrontera (BFRI) is a biopharmaceutical company commercializing Ameluz, a photodynamic therapy (light treatment) for actinic keratosis (a skin precancer) in the United States. This includes R&D and commercialization. This chart shows the market-standard profitability per employee. It helps assess how effectively BFRI utilizes its sales force to generate revenue.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772553602515 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Biofrontera Inc. (BFRI)
Biofrontera is a pharmaceutical company specializing in photodynamic therapy for dermatology. This chart shows the company's success in commercializing this niche medical treatment. It reflects how successfully it sells its drugs and devices to dermatologists.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Biofrontera-Inc.-BFRI&v=1772553602556 "Sales chart per company employee Biofrontera Inc. (BFRI)")
Sales per employee in the market segment - Pharma skin
Biofrontera is a commercial pharmaceutical company specializing in dermatology products, specifically photodynamic therapy for actinic keratosis. This chart shows the average revenue per employee in this segment. It helps assess how effectively Biofrontera monetizes its products compared to its competitors.
Sales per employee for the market as a whole
Biofrontera is a pharmaceutical company specializing in dermatology. They are commercializing a drug for photodynamic therapy of actinic keratosis (a precancerous skin condition). This chart shows how effectively their sales team is promoting this specialized therapy to dermatologists.
Short shares by company, segment and market as a whole
Shares shorted by company Biofrontera Inc. (BFRI)
Biofrontera is a company that sells photodynamic therapy (gel and lamp) in the US for the treatment of actinic keratosis (a precancerous skin condition). This chart shows the odds that their product will lose out to the competition. "Bears" believe their treatment method is inferior to other treatments (cryotherapy, creams) and will not be able to capture a significant market share.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Biofrontera-Inc.-BFRI&v=1772553602697 "Short Shares Chart for the Company Biofrontera Inc. (BFRI)")
Shares shorted by market segment - Pharma skin
Biofrontera Inc. (BFRI) is a biopharmaceutical company specializing in dermatology. They market photodynamic therapy drugs for actinic keratosis (a precancerous skin condition) in the US. This chart shows the overall short position in the dermatology biotech sector. Its rise reflects investor doubts about the commercial success of drugs in this niche.
Shares shorted by the overall market
Biofrontera (BFRI) is a pharmaceutical company focused on dermatology. When this fear indicator rises, investors worry that a recession will (1) cause patients to forgo expensive, "non-essential" skin treatments and (2) prevent the company from refinancing its debt.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Biofrontera Inc. (BFRI)
Biofrontera (BFRI) specializes in dermatological drugs, specifically photodynamic therapy for actinic keratosis (a precancerous skin condition). This chart measures the strength of buyers. It shows when the stock enters overbought (above 70) or oversold (below 30) territory, which is often associated with sales reports or insurance company decisions.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Biofrontera-Inc.-BFRI&v=1772553603042 "RSI 14 indicator chart for the company's stock Biofrontera Inc. (BFRI)")
RSI 14 Market Segment - Pharma skin
Biofrontera Inc. is an American pharmaceutical company specializing in dermatology. Its key product is photodynamic therapy (a combination of gel and light) for the treatment of precancerous skin lesions. This chart shows the overall sentiment in the skin pharmaceutical sector. It helps us understand whether the BFRI trend reflects its commercial success or a general trend.
RSI 14 for the overall market
Biofrontera (BFRI) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast BFRI (Biofrontera Inc.)
Biofrontera specializes in dermatology, commercializing Ameluz, a photodynamic therapy (drug plus light), for the treatment of actinic keratosis (pre-cancer). This chart shows the average analyst forecast. Their targets are based on Ameluz sales growth, market share, and reimbursement policy.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-BFRI-Biofrontera-Inc.&v=1772553603448 "A chart showing analyst consensus forecasts for the expected stock price. BFRI (Biofrontera Inc.)")
The difference between the consensus estimate and the actual stock price BFRI (Biofrontera Inc.)
Biofrontera is a German biopharmaceutical company specializing in photodynamic therapy (light and gel) for the treatment of skin cancer. This chart shows the upside and downside potential analysts see for the stock. It measures the gap between the price and forecast, reflecting their belief in the commercial success of this dermatological procedure.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-BFRI-Biofrontera-Inc.&v=1772553603466 "A chart showing the difference between the consensus forecast and the actual stock price. BFRI (Biofrontera Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharma skin
Biofrontera is a dermatology company that markets Ameluz, a photodynamic therapy (light-activated) for the treatment of precancerous skin lesions. This chart shows analysts' overall expectations for the skin pharmaceutical sector. It reflects whether experts believe the light therapy market will grow.
Analysts' consensus forecast for the overall market share price
Biofrontera (BFRI) is a "light-based" dermatology company. They sell a drug (Ameluz) and a lamp that are used together for "photodynamic" therapy of actinic keratosis (a precancerous skin condition). This chart shows the general sentiment of experts. It reflects the analysts' confidence in the stability of spending on "elective" dermatology.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Biofrontera Inc.
Biofrontera is a light-based oncology company. Their signature technique is photodynamic therapy (PDT): they sell a cream (Ameluz) that is absorbed by skin cancer cells and then activated by a special light, killing the cancer. This graph is a summary of their razor and blade products. It reflects their sales of the cream (blades) and their light-based lamps (razors).
AKIMA Market Segment Index - Pharma skin
Biofrontera (BFRI) is a commercial dermatology company. Their primary business is selling Ameluz, a drug used in photodynamic therapy (PDT) for the treatment of actinic keratosis (a precancerous skin condition). This chart shows the average index for the segment. It helps assess how successfully BFRI is commercializing its product compared to the average.
The AKIM Index for the overall market
Biofrontera is a biopharmaceutical company specializing in dermatology. It sells Ameluz (photodynamic therapy) for the treatment of keratosis. This chart, which reflects the market average, provides a macro backdrop. It helps assess how BFRI, the commercial dermatology company, compares to overall economic trends.
